Basic mechanisms of kynurenine actions in the central nervous system.
Stone
T W
TW
Institute of Biomedical and Life Sciences, University of Glasgow, Scotland.
MacGregor
D G
DG
Smith
R A
RA
Jones
P
P
Behan
W M
WM
Graham
D I
DI
D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology; D002490:Central Nervous System / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D007211:Indoles / Q000378:metabolism / Q000494:pharmacology; D007736:Kynurenic Acid / Q000378:metabolism / Q000494:pharmacology; D007737:Kynurenine / Q000031:analogs & derivatives / Q000378:metabolism / Q000494:pharmacology / Q000502:physiology*; D008322:Mammals; D009474:Neurons / Q000502:physiology; D018696:Neuroprotective Agents / Q000494:pharmacology; D017378:Quinolinic Acid / Q000378:metabolism; D016194:Receptors, N-Methyl-D-Aspartate / Q000502:physiology
D000927:Anticonvulsants; D007211:Indoles; D018696:Neuroprotective Agents; D016194:Receptors, N-Methyl-D-Aspartate; D007737:Kynurenine; C008122:indol-3-yl pyruvic acid; D017378:Quinolinic Acid; D007736:Kynurenic Acid